Blood eosinophil count as a prognostic biomarker in COPD

References

• RabeKFHurdSAnzuetoAGlobal Initiative for Chronic Obstructive Lung DiseaseGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2007176653255517507545
   PubMed Web of Science ®Google Scholar
• VogelmeierCFCrinerGJMartinezFJGlobal Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive SummaryAm J Respir Crit Care Med2017195555758228128970
   PubMed Web of Science ®Google Scholar
• PavordIDLettisSAnzuetoABarnesNBlood eosinophil count and pneumonia risk in patients with chronic obstructive pulmonary disease: a patient-level meta-analysisLancet Respir Med20164973174127460163
   PubMed Web of Science ®Google Scholar
• PavordIDLettisSLocantoreNBlood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPDThorax201671211812526585525
   PubMed Web of Science ®Google Scholar
• BafadhelMDaviesLCalverleyPMAaronSDBrightlingCEPavordIDBlood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysisEur Respir J201444378979124925917
   PubMed Web of Science ®Google Scholar
• KerkhofMSonnappaSPostmaDSBlood eosinophil count and exacerbation risk in patients with COPDEur Respir J2017501pii:1700761
   Web of Science ®Google Scholar
• PavordIDAgustiABlood eosinophil count: a biomarker of an important treatable trait in patients with airway diseaseEur Respir J20164751299130327132257
   PubMed Web of Science ®Google Scholar
• NishimuraMMakitaHNagaiKHokkaido COPD Cohort Study InvestigatorsAnnual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20121851445222016444
   PubMed Web of Science ®Google Scholar
• PapaioannouAIKostikasKPapaporfyriouAEmphysematous phenotype is characterized by low blood Eosinophils: A Cross-Sectional StudyCOPD201714663564029099646
   PubMedGoogle Scholar
• OhYMParkJHKimEKAnemia as a clinical marker of stable chronic obstructive pulmonary disease in the Korean obstructive lung disease cohortJ Thorac Dis20179125008501629312705
   PubMed Web of Science ®Google Scholar
• LeeHHongYLimMNInflammatory biomarkers and radiologic measurements in never-smokers with COPD: a cross-sectional study from the CODA cohortChron Respir Dis201815213814529117798
   PubMed Web of Science ®Google Scholar
• OhYMSheenSSParkJHEmphysematous phenotype is an independent predictor for frequent exacerbation of COPDInt J Tuberc Lung Dis201418121407141425517804
   PubMed Web of Science ®Google Scholar
• ATS Committee on Proficiency Standards for Clinical Pulmonary Function LaboratoriesATS statement: guidelines for the six-minute walk testAm J Respir Crit Care Med2002166111111712091180
   PubMed Web of Science ®Google Scholar
• MillerMRHankinsonJBrusascoVATS/ERS Task ForceStandardisation of spirometryEur Respir J200526231933816055882
   PubMed Web of Science ®Google Scholar
• HwangYIKimCHKangHRComparison of the prevalence of chronic obstructive pulmonary disease diagnosed by lower limit of normal and fixed ratio criteriaJ Korean Med Sci200924462162619654942
   PubMed Web of Science ®Google Scholar
• WangerJClausenJLCoatesAStandardisation of the measurement of lung volumesEur Respir J200526351152216135736
   PubMed Web of Science ®Google Scholar
• MacintyreNCrapoROViegiGStandardisation of the single-breath determination of carbon monoxide uptake in the lungEur Respir J200526472073516204605
   PubMed Web of Science ®Google Scholar
• NakanoYMuroSSakaiHComputed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung functionAm J Respir Crit Care Med20001623 Pt 11102110810988137
   PubMed Web of Science ®Google Scholar
• LeeYKOhYMLeeJHQuantitative assessment of emphysema, air trapping, and airway thickening on computed tomographyLung2008186315716518351420
   PubMed Web of Science ®Google Scholar
• VestboJEdwardsLDScanlonPDECLIPSE InvestigatorsChanges in forced expiratory volume in 1 second over time in COPDN Engl J Med2011365131184119221991892
   PubMed Web of Science ®Google Scholar
• HongYLeeJSYooKHImplications of emphysema and lung function for the development of pneumonia in patients with chronic obstructive pulmonary diseaseTuberc Respir Dis (Seoul)2016792919727066086
   PubMedGoogle Scholar
• NaitoKYamasakiKYateraKBacteriological incidence in pneumonia patients with pulmonary emphysema: a bacterial floral analysis using the 16S ribosomal RNA gene in bronchoalveolar lavage fluidInt J Chron Obstruct Pulmon Dis2017122111212028790814
   PubMed Web of Science ®Google Scholar
• MakitaHNasuharaYNagaiKHokkaido COPD Cohort Study GroupCharacterisation of phenotypes based on severity of emphysema in chronic obstructive pulmonary diseaseThorax2007621193293717573447
   PubMed Web of Science ®Google Scholar
• GietemaHAEdwardsLDCoxsonHOBakkePSECLIPSE InvestigatorsImpact of emphysema and airway wall thickness on quality of life in smoking-related COPDRespir Med201310781201120923711580
   PubMed Web of Science ®Google Scholar
• LeeJHLeeYKKimEKResponses to inhaled long-acting beta-agonist and corticosteroid according to COPD subtypeRespir Med2010104454254919926461
   PubMed Web of Science ®Google Scholar
• ParkHYLeeHKohWJKOLD Study GroupAssociation of blood eosinophils and plasma periostin with FEV1 response after 3-month inhaled corticosteroid and long-acting beta2-agonist treatment in stable COPD patientsInt J Chron Obstruct Pulmon Dis201611233026730185
   PubMed Web of Science ®Google Scholar
• LeeJSHuhJWChaeEJPredictors of pulmonary function response to treatment with salmeterol/fluticasone in patients with chronic obstructive pulmonary diseaseJ Korean Med Sci201126337938521394306
   PubMed Web of Science ®Google Scholar
• ContoliMPaulettiARossiMRLong-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPDEur Respir J2017504170045128982774
   PubMed Web of Science ®Google Scholar
• PascoeSLocantoreNDransfieldMTBarnesNCPavordIDBlood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trialsLancet Respir Med20153643544225878028
   PubMed Web of Science ®Google Scholar
• CasanovaCCelliBRde-TorresJPPrevalence of persistent blood eosinophilia: relation to outcomes in patients with COPDEur Respir J2017505170116229167301
   PubMed Web of Science ®Google Scholar
• ZysmanMDesleeGCaillaudDRelationship between blood eosinophils, clinical characteristics, and mortality in patients with COPDInt J Chron Obstruct Pulmon Dis2017121819182428694695
   PubMed Web of Science ®Google Scholar